May 17, 2022
BREAKING NEWS
ASH 2021: Dr. Jennifer Woyach with an Update on Ibrutinib vs. Chemoimmunotherapy as a Frontline Treatment for Chronic Lymphocytic Leukemia
An Immunologist Reviews CLL/SLL Patients and Their Compromised Immunity
Application of National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for CLL/SLL from the informCLL Real-World Registry
ASH 2021: Age-Related Differences in the Informational Experiences and Needs of Patients with Lymphoma: Results from the 2020 Lymphoma Coalition Global Patient Survey

Support Groups  |  Researchers

Smart Patients Get Smart Care™

The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients

Newsletter Sign Up
Donate Now

  • HOME
  • What’s New
  • CLL Information & Management
    • Newly Diagnosed
      • Newly Diagnosed
      • CLL/SLL Patient Education Toolkit
      • Watch and Wait
      • Build Your Care Team
      • CLL Doctors
      • CLL Symptoms
      • Basic Biology of CLL
      • Staging
      • Complications
      • CLL Testing & Imaging
        • CLL Testing & Imaging
        • CLL Diagnosis
        • Test Before Treat™
    • Treatment and Research
      • Treatment and Research
      • Watch and Wait
      • Indications for Treatment
      • Medications
      • Clinical Trials
        • Clinical Trials
        • Clinical Trial Basics
        • Opening Trials & Status Updates
        • Clinical Trial Results
        • The Patient Perspective
      • Targeted Therapies
      • Immunotherapy
      • Chemotherapy
      • CAR-T and Other Cellular Therapies
      • Frontline Therapies
      • Relapsed/Refractory or Later Therapies
      • Richter’s Transformation
      • MRD and Disease Monitoring
    • CLL Resources
      • CLL Resources
      • Normal CLL Lab Values
      • Keeping Track of Lab Results
      • CLL Doctors
      • CLL Glossary
      • Abbreviations & Acronyms
      • Ask the Experts
      • CLL/SLL Patient Education Toolkit
    • Opinions and Insights
    • Industry, Insurance and Regulatory News
  • Programs & Support
    • Ask the Experts
    • Support Groups
      • CLL-Specific Patient Support Groups
      • CLL Society Support Groups Interactive Map
      • Support Group Calendar
      • Support Group Leader Resources
    • Upcoming Events
      • Educational Events
      • Other Events
    • Expert Access™
    • Education On-Demand
  • COVID-19
    • COVID-19 Action Plan
    • COVID-19 Updates
    • COVID-19 Prevention & Treatment
    • COVID-19 Official Statements
    • COVID-19 Virtual Community Meetings
    • COVID-19 General Information
  • Living With CLL
    • Stories and Testimonials
    • Financial Resources
      • Financial Resources
      • Insurance Resources
    • Dr. Koffman’s Blogs
    • Creative Corner
    • Being Your Own Advocate
    • Caregivers
    • Surveys
  • About Us
    • CLL Society in the News
    • Our Story, Mission, and Vision
    • Advocacy
    • Scientific Publications
    • CLL Society Funded Research
      • About CLL Society’s Research Grant Program
      • Current Funding Opportunities
      • Apply for a Grant
        • Apply
        • Eligibility
        • Selection and Review Process
      • Support Our Efforts
    • Who We Are
      • Board of Directors
      • Medical Advisory Board
      • Expert Medical Council
      • Patient Advisory Board
      • CLL Society Staff
    • Volunteers
    • Contact Us
    • CLL Society Industry Advisory Council
  • Donate
Menu
  • HOME
  • What’s New
  • CLL Information & Management
    • Newly Diagnosed
      • Newly Diagnosed
      • CLL/SLL Patient Education Toolkit
      • Watch and Wait
      • Build Your Care Team
      • CLL Doctors
      • CLL Symptoms
      • Basic Biology of CLL
      • Staging
      • Complications
      • CLL Testing & Imaging
        • CLL Testing & Imaging
        • CLL Diagnosis
        • Test Before Treat™
    • Treatment and Research
      • Treatment and Research
      • Watch and Wait
      • Indications for Treatment
      • Medications
      • Clinical Trials
        • Clinical Trials
        • Clinical Trial Basics
        • Opening Trials & Status Updates
        • Clinical Trial Results
        • The Patient Perspective
      • Targeted Therapies
      • Immunotherapy
      • Chemotherapy
      • CAR-T and Other Cellular Therapies
      • Frontline Therapies
      • Relapsed/Refractory or Later Therapies
      • Richter’s Transformation
      • MRD and Disease Monitoring
    • CLL Resources
      • CLL Resources
      • Normal CLL Lab Values
      • Keeping Track of Lab Results
      • CLL Doctors
      • CLL Glossary
      • Abbreviations & Acronyms
      • Ask the Experts
      • CLL/SLL Patient Education Toolkit
    • Opinions and Insights
    • Industry, Insurance and Regulatory News
  • Programs & Support
    • Ask the Experts
    • Support Groups
      • CLL-Specific Patient Support Groups
      • CLL Society Support Groups Interactive Map
      • Support Group Calendar
      • Support Group Leader Resources
    • Upcoming Events
      • Educational Events
      • Other Events
    • Expert Access™
    • Education On-Demand
  • COVID-19
    • COVID-19 Action Plan
    • COVID-19 Updates
    • COVID-19 Prevention & Treatment
    • COVID-19 Official Statements
    • COVID-19 Virtual Community Meetings
    • COVID-19 General Information
  • Living With CLL
    • Stories and Testimonials
    • Financial Resources
      • Financial Resources
      • Insurance Resources
    • Dr. Koffman’s Blogs
    • Creative Corner
    • Being Your Own Advocate
    • Caregivers
    • Surveys
  • About Us
    • CLL Society in the News
    • Our Story, Mission, and Vision
    • Advocacy
    • Scientific Publications
    • CLL Society Funded Research
      • About CLL Society’s Research Grant Program
      • Current Funding Opportunities
      • Apply for a Grant
        • Apply
        • Eligibility
        • Selection and Review Process
      • Support Our Efforts
    • Who We Are
      • Board of Directors
      • Medical Advisory Board
      • Expert Medical Council
      • Patient Advisory Board
      • CLL Society Staff
    • Volunteers
    • Contact Us
    • CLL Society Industry Advisory Council
  • Donate

Support Groups  |  Researchers

Home » CLL/SLL Patient Education Toolkit » CLL Society Website Resources

CLL Society Resources and Services

In this video, CLL Society Communications Director Patricia Koffman explains the following CLL Society Services and Resources:

  • Test Before Treat™ at 00:00 – 7:38
  • CLL Society Support Groups 7:38 – 8:26
  • Expert Access™ at 8:27 – 12:12
  • Weekly Newsletter Signup 12:13 – 12:27 
  • 130,000 Campaign 12:28 – 13:14
Introduction/Overview

CLL/SLL Patient Education Toolkit Home

Overview of CLL Society Programs

About CLL/SLL and its Treatment

What is CLL, and What is SLL?

CLL Symptoms

CLL Staging and Other Prognostic Factors

Test Before Treat™

Watch and Wait (Active Observation)

Brief Overview of Types of Treatments

CLL Approved Medications

FAQ — Treatment

FAQ — Overall Health, Well-Being and Risks

CLL-Related Fatigue

Complications of CLL

Managing Side Effects of Oral Targeted Therapies in CLL

Getting to Know Your Body

What is Bone Marrow?

What is a Lymph Node?

What is the Spleen?

What is Blood Made Of?

CLL Tools

Abbreviations and Acronyms

Glossary: Blood (Hematology) Tests

Normal Lab Values

Keeping Track of Lab Results

Clinical Trial Phases, the Drug Approval Process, and Measuring Responses

Putting Together a CLL Team

CLL Website Resources

Financial Assistance Part 1 — Nonprofits and Government

Financial Assistance Part 2 — Industry Sponsored

CLL SOCIETY FAST FIND

One click to our most popular content.

xFINAL Newly Diagnosed 150x107
xFINAL Treatment And Research 107
xFINAL Normal Lab Values 32122
xFINAL Free CLL Expwert Opinion 107
quicklinks
QUICK LINKS

UPCOMING
EVENTS

CLL SOCIETY
SUPPORT GROUPS

LIST OF OFFICIAL
CLL DOCTORS

OFFICIAL STATEMENTS AND GUIDELINES

CLL GLOSSARY

CLL SOCIETY
IN THE NEWS

ABOUT US

CLL Society Inc. is a patient–centric, physician–curated nonprofit organization focused on patient education, support, and research. Dedicated to addressing the unmet needs of the chronic lymphocytic leukemia (CLL) and related blood cancer communities, we explain the rapidly changing therapeutic landscape and the importance of clinical trials, support and build patient networks, engage in research, and educate providers and patients.

TERMS AND CONDITIONS

PRIVACY POLICY

REPORT A BUG

CONTACT

1454 Melrose Ave.
Ste 1-247
Chula Vista, CA 91911
Send us a message

Facebook Twitter Linkedin

Copyright 2022 © CLL Society, Inc. All rights Reserved.